DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

71.04 -0.85 (-1.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AZN $71.04 -1.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.81
Previous Close $71.89
Daily Range $70.94 - $72.16
52-Week Range $61.75 - $82.68
Market Cap $89.7B
P/E Ratio 35.24
Dividend (Yield) $1.80 (3.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,715,204
Average Daily Volume 1,580,208
Current FY EPS $4.35





AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website:

News & Commentary Rss Feed

Bristol-Myers Squibb Co.'s Fourth Quarter Earnings Warn of a Tough Year Ahead

Bristol-Myers Squibb Co. reported its fourth quarter earnings Tuesday morning. Here's what investors need to know.

Teva Gains FDA Nod for Generic of AstraZeneca's Nexium - Analyst Blog

Bristol-Myers Beats on Q4 Earnings, 2015 View Disappoints - Analyst Blog

3 Health Care Stocks Pushing The Sector Higher

Benzinga's Volume Movers

Pfizer Inc.'s Fourth-Quarter Earnings Hint at Big Things to Come

Pfizer Inc. reported its fourth-quarter earnings before the bell this morning. Here's what investors need to know going forward.

Pre-Market Activity Shows Heavy Volume And Movement For AstraZeneca (AZN)

Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead

3 Motley Fool contributors offer up suggestions on what they believe Pfizer should acquire.

Is A Generic Nexium Purple Pill For You?

AstraZeneca's Regulatory Filing for Lesinurad Accepted - Analyst Blog

See More AZN News...

AZN's Top Competitors

AZN $71.04 (-1.18%)
Current stock: AZN
JNJ $100.14 (-2.19%)
Current stock: JNJ
NVS $97.40 (-1.77%)
Current stock: NVS
RHHBY $33.78 (-1.75%)
Current stock: RHHBY